Warning letterFDA · Mar 16, 2021
Anna Health, LLC MARCS-CMS 613294, March 16, 2021
Named company: Anna Health, LLC
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, the Fucoidan, Prostate Health, Children…
Lot information: not specified in this record.